These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31305262)

  • 1. Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance.
    Spudich S; Robertson KR; Bosch RJ; Gandhi RT; Cyktor JC; Mar H; Macatangay BJ; Lalama CM; Rinaldo C; Collier AC; Godfrey C; Eron JJ; McMahon D; Jacobs JL; Koontz D; Hogg E; Vecchio A; Mellors JW
    J Clin Invest; 2019 Jul; 129(8):3339-3346. PubMed ID: 31305262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations.
    Oliveira MF; Chaillon A; Nakazawa M; Vargas M; Letendre SL; Strain MC; Ellis RJ; Morris S; Little SJ; Smith DM; Gianella S
    PLoS Pathog; 2017 Jan; 13(1):e1006112. PubMed ID: 28046096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy.
    Wagner TA; Tierney C; Huang S; Nichols S; Malee KM; Montañez NA; Coletti A; Spiegel HML; Krotje C; Bone F; Wilkins M; Abuogi L; Purswani M; Bearden A; Wiznia A; Agwu A; Chadwick EG; Richman D; Gandhi M; Mehta P; Macatangay B; Spector SA; Spudich S; Persaud D; Chahroudi A;
    AIDS; 2024 Aug; 38(10):1494-1504. PubMed ID: 38814693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals.
    Pérez-Santiago J; De Oliveira MF; Var SR; Day TRC; Woods SP; Gianella S; Mehta SR
    J Neurovirol; 2017 Apr; 23(2):283-289. PubMed ID: 27921220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Analysis of Cell-Associated HIV DNA Levels in Cerebrospinal Fluid and Peripheral Blood by Droplet Digital PCR.
    de Oliveira MF; Gianella S; Letendre S; Scheffler K; Kosakovsky Pond SL; Smith DM; Strain M; Ellis RJ
    PLoS One; 2015; 10(10):e0139510. PubMed ID: 26431315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy: A Cohort Study.
    Hoenigl M; de Oliveira MF; Pérez-Santiago J; Zhang Y; Morris S; McCutchan AJ; Finkelman M; Marcotte TD; Ellis RJ; Gianella S
    Medicine (Baltimore); 2016 Mar; 95(11):e3162. PubMed ID: 26986173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
    Anderson AM; Muñoz-Moreno JA; McClernon DR; Ellis RJ; Cookson D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Franklin DR; Heaton RK; Grant I; Letendre SL;
    J Infect Dis; 2017 Jan; 215(1):105-113. PubMed ID: 27789723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.
    Livelli A; Vaida F; Ellis RJ; Ma Q; Ferrara M; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Grant I; Letendre SL;
    Lancet HIV; 2019 Jul; 6(7):e456-e462. PubMed ID: 31208949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults.
    Patton SM; Wang Q; Hulgan T; Connor JR; Jia P; Zhao Z; Letendre SL; Ellis RJ; Bush WS; Samuels DC; Franklin DR; Kaur H; Iudicello J; Grant I; Kallianpur AR
    Fluids Barriers CNS; 2017 Apr; 14(1):11. PubMed ID: 28427421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.
    Letendre S; Bharti A; Perez-Valero I; Hanson B; Franklin D; Woods SP; Gianella S; de Oliveira MF; Heaton RK; Grant I; Landay AL; Lurain N;
    Clin Infect Dis; 2018 Aug; 67(5):770-777. PubMed ID: 29506084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study.
    Anderson AM; Tang B; Vaida F; Mcclernon D; Deutsch R; Cherner M; Cookson D; Crescini M; Grant I; Ellis RJ; Letendre SL
    J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1196-1204. PubMed ID: 33901102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy.
    Dahl V; Lee E; Peterson J; Spudich SS; Leppla I; Sinclair E; Fuchs D; Palmer S; Price RW
    J Infect Dis; 2011 Dec; 204(12):1936-45. PubMed ID: 22021620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.
    Dahl V; Peterson J; Fuchs D; Gisslen M; Palmer S; Price RW
    AIDS; 2014 Sep; 28(15):2251-8. PubMed ID: 25022595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
    Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
    HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical factors related to brain structure in HIV: the CHARTER study.
    Jernigan TL; Archibald SL; Fennema-Notestine C; Taylor MJ; Theilmann RJ; Julaton MD; Notestine RJ; Wolfson T; Letendre SL; Ellis RJ; Heaton RK; Gamst AC; Franklin DR; Clifford DB; Collier AC; Gelman BB; Marra C; McArthur JC; McCutchan JA; Morgello S; Simpson DM; Grant I;
    J Neurovirol; 2011 Jun; 17(3):248-57. PubMed ID: 21544705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
    Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
    J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
    Spudich SS; Nilsson AC; Lollo ND; Liegler TJ; Petropoulos CJ; Deeks SG; Paxinos EE; Price RW
    BMC Infect Dis; 2005 Nov; 5():98. PubMed ID: 16266436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.
    Pérez-Valero I; Ellis R; Heaton R; Deutsch R; Franklin D; Clifford DB; Collier A; Gelman B; Marra C; McCutchan JA; Navis A; Sacktor N; Simpson D; Grant I; Letendre S
    AIDS; 2019 Mar; 33(3):475-481. PubMed ID: 30702516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND).
    Schrier RD; Hong S; Crescini M; Ellis R; Pérez-Santiago J; Spina C; Letendre S;
    PLoS One; 2015; 10(2):e0116526. PubMed ID: 25719800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
    Henrich TJ; Hatano H; Bacon O; Hogan LE; Rutishauser R; Hill A; Kearney MF; Anderson EM; Buchbinder SP; Cohen SE; Abdel-Mohsen M; Pohlmeyer CW; Fromentin R; Hoh R; Liu AY; McCune JM; Spindler J; Metcalf-Pate K; Hobbs KS; Thanh C; Gibson EA; Kuritzkes DR; Siliciano RF; Price RW; Richman DD; Chomont N; Siliciano JD; Mellors JW; Yukl SA; Blankson JN; Liegler T; Deeks SG
    PLoS Med; 2017 Nov; 14(11):e1002417. PubMed ID: 29112956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.